Privia Health Group, Inc.
Business
Privia Health Group, Inc. is a physician-enablement company that organizes primary-care physicians and clinicians into value-based medical groups across 24 states and the District of Columbia. The company provides practice management, population health analytics, revenue cycle management, and clinical operations support to help providers transition from fee-for-service to value-based care. Privia operates through owned medical groups, non-owned medical groups via service agreements, and affiliated Accountable Care Organizations.
Summary from 10-K filed 2026-02-27
Financials
Consolidated Statement of Income
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenue | 2,123 | 1,736 | 1,658 | 1,357 | 966 | |
| Provider expense | 1,661 | 1,333 | 1,299 | 1,051 | 728 | |
| Cost of platform | 253 | 227 | 198 | 171 | 175 | |
| Sales and marketing | 27 | 26 | 25 | 20 | 23 | |
| General and administrative | 138 | 126 | 110 | 130 | 256 | |
| Depreciation and amortization | 10 | 7 | 7 | 5 | 2 | |
| Total operating expenses | 2,089 | 1,719 | 1,637 | 1,376 | 1,184 | |
| Operating income | 34 | 17 | 21 | −19 | −217 | |
| Interest income, net | 10 | 11 | 8 | 542,000 | — | |
| Income before provision for income taxes | 44 | 28 | 29 | −19 | −219 | |
| Provision for income taxes | 14 | 11 | 8 | −7 | −28 | |
| Net income | 30 | 17 | 21 | −12 | −191 | |
| Less: Net income (loss) attributable to non-controlling interests | 7 | 3 | −2 | −3 | −2 | |
| Net income attributable to Privia Health Group, Inc. | 23 | 14 | 23 | −9 | −188 | |
| Net income per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share) | 0.19 | 0.12 | 0.2 | −0.08 | −1.83 | |
| Net income per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share) | 0.18 | 0.11 | 0.19 | −0.08 | −1.83 | |
| Weighted average common shares outstanding - basic (in shares) | 122 | 119 | 117 | 111 | 103 | |
| Weighted average common shares outstanding diluted (in shares) | 129 | 126 | 125 | 111 | 103 |
Consolidated Balance Sheet
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 480 | 491 | 390 | 348 | 321 | |
| Accounts receivable, net of allowance for credit losses of $15.4 million and $9.3 million | 401 | 316 | 291 | 190 | 117 | |
| Prepaid expenses and other current assets | 30 | 27 | 21 | 14 | 9 | |
| Total current assets | 911 | 835 | 701 | 552 | 447 | |
| Property and equipment, net | 504,000 | 1 | 2 | 3 | 5 | |
| Right-of-use assets | 9 | 5 | 7 | 8 | 10 | |
| Intangible assets, net | 216 | 110 | 108 | 57 | 60 | |
| Goodwill | 210 | 142 | 139 | 127 | 128 | |
| Deferred tax asset, net | 2 | 26 | 35 | 40 | 33 | |
| Other non-current assets | 21 | 17 | 9 | 5 | 5 | |
| Total non-current assets | 458 | 301 | 299 | 241 | 240 | |
| Total assets | 1,369 | 1,136 | 1,000 | 793 | 686 | |
| Accounts payable and accrued expenses | 97 | 82 | 58 | 53 | 46 | |
| Provider liability | 470 | 365 | 326 | 208 | — | |
| Operating lease liabilities, current | 2 | 3 | 3 | 3 | 3 | |
| Total current liabilities | 569 | 449 | 387 | 264 | 190 | |
| Operating lease liabilities, non-current | 7 | 3 | 5 | 8 | 11 | |
| Other non-current liabilities | 3 | 153,000 | 313,000 | 1 | 3 | |
| Total non-current liabilities | 10 | 3 | 6 | 9 | 46 | |
| Total liabilities | 578 | 452 | 393 | 274 | 236 | |
| Commitments and contingencies (Note 13.) | — | — | — | — | — | |
| Common stock, $0.01 par value, 1,000,000,000 shares authorized; 123,604,576 and 120,309,346 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively | 1 | 1 | 1 | 1 | 1 | |
| Additional paid-in capital | 892 | 813 | 754 | 715 | 634 | |
| Accumulated deficit | −156 | −179 | −194 | −217 | −208 | |
| Total Privia Health Group, Inc. stockholders equity | 737 | 635 | 561 | 499 | 427 | |
| Non-controlling interest | 54 | 48 | 46 | 20 | 23 | |
| Total stockholders equity | 791 | 683 | 607 | 519 | 450 | |
| Total liabilities and stockholders equity | 1,369 | 1,136 | 1,000 | 793 | 686 |
Consolidated Statement of Cash Flows
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Depreciation | 739,000 | 1 | 1 | 1 | 1 | |
| Amortization of intangibles | 9 | 6 | 5 | 3 | 1 | |
| Stock-based compensation | 71 | 57 | 37 | 67 | 254 | |
| Deferred income taxes | 11 | 9 | 7 | −7 | −28 | |
| Accounts receivable, net | −37 | −20 | −97 | −72 | −15 | |
| Prepaid expenses and other current assets | −2 | −9 | −6 | −6 | −1 | |
| Other non-current assets and right-of-use assets | −326,000 | −2 | −2 | 1 | −10 | |
| Accounts payable and accrued expenses | 15 | 20 | 5 | 7 | 1 | |
| Provider liability | 66 | 33 | 113 | — | — | |
| Operating lease liabilities | −2 | −3 | −3 | −2 | 14 | |
| Other long-term liabilities | 2 | −160,000 | −1 | −2 | −6 | |
| Net cash provided by operating activities | 163 | 109 | 81 | 47 | 55 | |
| Acquisitions, net of cash acquired | −180 | −7 | −43 | 0 | −32 | |
| Other | −1 | −5 | −113,000 | −104,000 | — | |
| Net cash used in investing activities | −182 | −12 | −43 | −104,000 | −33 | |
| Repurchase of non-controlling interest | 0 | 0 | −6 | 0 | 0 | |
| Proceeds from non-controlling interest | 0 | 2 | 659,000 | 125,000 | 0 | |
| Distribution to non-controlling interest | −1 | 0 | 0 | — | — | |
| Proceeds from exercised stock options | 8 | 3 | 9 | 13 | 4 | |
| Net cash provided by financing activities | 7 | 4 | 4 | −20 | 214 | |
| Net (decrease) increase in cash and cash equivalents | −11 | 102 | 42 | 27 | 236 | |
| Interest paid | 251,000 | 285,000 | 40,000 | 713,000 | 888,000 | |
| Income taxes paid, net of refunds | 7 | 4 | 1 | 307,000 | 504,000 | |
| Leases liabilities obtained in exchange for right-of-use assets | 6 | 0 | 0 | — | — |
Filings
Material Events
Insiders
Institutional Holders
Frequently asked questions
What is Privia Health Group, Inc.'s CIK number?
Privia Health Group, Inc.'s SEC CIK number is 0001759655 (1759655). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Privia Health Group, Inc.'s SEC filings?
All of Privia Health Group, Inc.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.
When did Privia Health Group, Inc. last report earnings?
Privia Health Group, Inc. (PRVA) most recently filed an earnings 8-K with the SEC on May 7, 2026, furnishing its results under Item 2.02 (Results of Operations and Financial Condition). The earnings press release is attached to that filing (accession 0001759655-26-000027). This is Privia Health Group, Inc.'s most recent earnings filing of record — not a forecast of its next earnings date.
What is Privia Health Group, Inc.'s most recent earnings 8-K?
Privia Health Group, Inc.'s latest earnings 8-K (Item 2.02) was filed May 7, 2026 under accession 0001759655-26-000027. It carries the quarterly or annual earnings press release — the earliest official, SEC-filed version of the results.
View Privia Health Group, Inc.'s latest earnings 8-K →
Look up any company's CIK number →